Monteiro S, Pinto J, Mira Coelho A, Leão M, Dória S
Department of Genetics, Faculty of Medicine, University of Porto, Porto, Portugal.
MMED, Master's Degree in Medicine, University of Porto, Porto, Portugal.
Neuropediatrics. 2019 Dec;50(6):367-377. doi: 10.1055/s-0039-1694797. Epub 2019 Aug 9.
Autism spectrum disorders (ASD) affect many children with an estimated prevalence of 1%. Array-comparative genomic hybridization (CGH) offers significant sensitivity for the identification of submicroscopic chromosomal abnormalities and it is one of the most used techniques in daily practice. The main objective of this study was to describe the usefulness of array-CGH in the etiologic diagnosis of ASD.
Two-hundred fifty-three patients admitted to a neurogenetic outpatient clinic and diagnosed with ASD were selected for array-CGH (4 × 180K microarrays). Public databases were used for classification in accordance with the American College of Medical Genetics Standards and Guidelines.
About 3.56% (9/253) of copy number variations (CNVs) were classified as pathogenic. When likely pathogenic CNVs were considered, the rate increased to 11.46% (29/253). Some CNVs apparently not correlated to the ASD were also found. Considering a phenotype-genotype correlation, the patients were divided in two groups. One group according to previous literature includes all the CNVs related to ASDs (23 CNVs present in 22 children) and another with those apparently not related to ASD (10 CNVs present in 7 children). In 18 patients, a next-generation sequencing (NGS) panel were performed. From these, one pathogenic and 16 uncertain significance variants were identified.
The results of our study are in accordance with the literature, highlighting the relevance of array-CGH in the genetic of diagnosis of ASD population, namely when associated with other features. Our study also reinforces the need for complementarity between array-CGH and NGS panels or whole exome sequencing in the etiological diagnosis of ASD.
自闭症谱系障碍(ASD)影响着许多儿童,估计患病率为1%。阵列比较基因组杂交(CGH)在识别亚微观染色体异常方面具有显著的敏感性,是日常实践中最常用的技术之一。本研究的主要目的是描述阵列CGH在ASD病因诊断中的作用。
选择253名在神经遗传学门诊就诊并被诊断为ASD的患者进行阵列CGH(4×180K微阵列)检测。根据美国医学遗传学学院的标准和指南,使用公共数据库进行分类。
约3.56%(9/253)的拷贝数变异(CNV)被分类为致病性变异。当考虑可能的致病性CNV时,该比率增至11.46%(29/253)。还发现了一些明显与ASD无关的CNV。考虑到表型-基因型相关性,将患者分为两组。一组根据先前的文献包括所有与ASD相关的CNV(22名儿童中存在23个CNV),另一组则是那些明显与ASD无关的CNV(7名儿童中存在10个CNV)。对18名患者进行了下一代测序(NGS)检测。从中鉴定出1个致病性变异和16个意义不明确的变异。
我们的研究结果与文献一致,突出了阵列CGH在ASD人群基因诊断中的相关性,特别是与其他特征相关时。我们的研究还强化了在ASD病因诊断中阵列CGH与NGS检测或全外显子测序之间互补性的必要性。